Trial Profile
A safety and feasibility study of administration of intracoronary bivalirudin bolus during primary percutaneous coronary interventions in comparison with standard intravenous route
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Dec 2015
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 28 Dec 2015 New trial record